This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Arena Pharmaceuticals, Inc.. Active years: 2016-2019.
Location History:
- San Diego, CA (US) (2016)
- Chicago, IL (US) (2017 - 2019)
Company Filing History:
Years Active: 2016-2019
Title: Martin C Cherrier: Innovator in Pharmaceutical Compositions
Introduction
Martin C Cherrier is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target serotonin receptors. With a total of 3 patents, his work has implications for various medical conditions.
Latest Patents
Cherrier's latest patents focus on pyrazole derivatives of Formula (Ia) and their pharmaceutical compositions. These compounds are designed to modulate the activity of the serotonin 5HT receptor. The applications of these inventions are extensive, addressing issues such as insomnia, platelet aggregation, coronary artery disease, and various psychotic disorders. His work also explores methods for treating serotonin receptor-mediated disorders in combination with other pharmaceutical agents.
Career Highlights
Throughout his career, Martin C Cherrier has worked with prominent companies in the pharmaceutical industry, including Arena Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. His innovative approach has led to advancements in treatments for a range of serious health conditions.
Collaborations
Cherrier has collaborated with notable professionals in his field, including Yifeng Xiong and Sonja Strah-Pleynet. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Martin C Cherrier's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to influence the treatment of various medical conditions, showcasing the importance of innovation in healthcare.